4月17日 -
** 蛋白质生物标记物检测平台Alamar Biosciences ALMR.O纳斯达克首秀有望高于发行价开盘
** 最近表示股票开盘价为每股22.50美元，而发行价为17美元
** 总部位于加利福尼亚州弗里蒙特的ALMR在规模扩大的首次公开募股中，以15-17美元发行区间的上限价格，出售了约1,130万股股票， (link) 募集资金1.913亿美元。
** 蛋白质组学公司开发出检测血液中低水平蛋白质生物标记物的仪器，为疾病研究和诊断提供了帮助
** J.P. Morgan、BofA Securities、TD Cowen、Leerink Partners 和 Stifel 担任此次发行的联合簿记管理人
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.